Sexual Functions and Covid-19

NCT ID: NCT05018065

Last Updated: 2021-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-01

Study Completion Date

2020-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sexual health is one the important components of life quality. The aim of this study is to compare sexual dysfunction of women who survived Covid-19 and who didn't undergo Covid-19.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With identifying a new type of coronavirus, the infection disease known as Coronavirus disease-2019 (Covid-19) is still effective worldwide. Within the frame of the description that the health is "a complete physical, mental and social welfare," many physical and mental modality may be expected due to the pandemic and the measures against pandemic. Among them, sexual health is one of the basic indicative factors of human welfare. There are few data on sexual dysfunctions from the previous clinic pandemic experiences. From the very early stages of Covid-19 pandemic, health systems and researches focused on mortalities and short-term morbidities. Although there are similar studies about effects of pandemic on sexual behaviors of general community, there is no comparative study about the effects on sexual functions of women survived from Covid-19 and women having no Covid-19 history, yet. This study aims to compare women survived from Covid-19 and women having no Covid-19 history and having similar characteristics in terms of sexual dysfunctions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19 Sexual Behavior

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

50 women previously diagnosed with mild - medium Covid-19 and had ambulatory care

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

Group Type ACTIVE_COMPARATOR

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

Intervention Type BEHAVIORAL

sexual dysfunction assesment

51 women having no Covid-19 history

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

Group Type ACTIVE_COMPARATOR

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

Intervention Type BEHAVIORAL

sexual dysfunction assesment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Women sexual dysfunctions were screened using Female Sexual Functioning Index (FSFI)

sexual dysfunction assesment

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* previously diagnosed for mild - medium Covid-19 infection and had ambulatory care
* being sexually active

Exclusion Criteria

* having psychiatric disease
* having any malignity
* having endometriosis
* having a gynecologic surgery history
* having a previous sexual dysfunction
Minimum Eligible Age

30 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gaziosmanpasa Research and Education Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fatma ketenci gencer

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saglık Bilimleri University Istanbul Gaziosmanpa Trainig and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GaziosmanpasaTREHe

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.